Annandale Capital, LLC - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
Annandale Capital, LLC ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$4
-100.0%
25,000
-42.6%
0.00%
-93.3%
Q2 2022$38,000
-65.5%
43,5320.0%0.02%
-65.1%
Q1 2022$110,000
-1.8%
43,5320.0%0.04%
-12.2%
Q4 2021$112,000
-43.7%
43,5320.0%0.05%
-59.2%
Q3 2021$199,000
-33.7%
43,5320.0%0.12%
-33.7%
Q2 2021$300,000
-6.0%
43,5320.0%0.18%
-19.9%
Q1 2021$319,000
-9.4%
43,5320.0%0.23%
-23.1%
Q4 2020$352,00043,5320.29%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q3 2022
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 367,346$926,0000.15%
DISCIPLINED GROWTH INVESTORS INC /MN 1,950,002$4,914,0000.11%
Claret Asset Management Corp 95,430$240,0000.05%
Annandale Capital, LLC 43,532$110,0000.04%
ARK Investment Management 861,798$2,172,0000.01%
Virtu Financial LLC 26,864$68,0000.01%
Ancora Advisors LLC 82,048$207,0000.01%
OSAIC HOLDINGS, INC. 4,600$1,372,0000.00%
TWO SIGMA SECURITIES, LLC 25,499$64,0000.00%
ATTICUS WEALTH MANAGEMENT, LLC 2,425$6,0000.00%
View complete list of REDHILL BIOPHARMA LTD shareholders